Design Therapeutics, Inc. (DSGN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 537.76M |
| Enterprise Value | 522.44M |
| P/E Ratio | -12.4 |
| PEG Ratio | 2.23 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.53 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -12.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.33 |
| Return On Equity | -0.34 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -622,000 |
| EBITDA | -69.17M |
| Net Income | -69.79M |
| Diluted EPS | -1.22 |
| Total Cash | 207.4M |
| Total Cash/Share | 3.32 |
| Total Debt | 2.03M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 18.86 |
| Book Value Per Share | 3.23 |
| 52-Week Change | 145.47 |
| 52-Week High | 17.25 |
| 52-Week Low | 5.28 |
| Moving Average 50 Days | 14.13 |
| Moving Average 200 Days | 11.75 |
| Average Volume | 691,103 |
| Shares Outstanding | 62.46M |
| % Held by Institutions | 69.72 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |